We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Medical

thymia

Status: Funded

Aug 1st 2023 - Aug 22nd 2023

Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings. 

read more read less
Log in to view amount pledged

    Log in to view target

    £11,437,500
    pre-money valuation

    8.97%
    equity available

    459
    investors

    £2,454
    pledge per investor

    12609104
    company number

    Active
    company status

    £8.13
    share price

    Previous Funding rounds
    12 May 24 Crowdcube £1,126,464 / 113%

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


Log in to view amount pledged

    Log in to view target

    £11,437,500
    pre-money valuation

    8.97%
    equity available

    459
    investors

    £2,454
    pledge per investor

    12609104
    company number

    Active
    company status

    £8.13
    share price

    Previous Funding rounds
    12 May 24 Crowdcube £1,126,464 / 113%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph